Culture & Entertainment · Philippines Bureau
Common Cough Medicine Shows Promise in Treating Solvent Addiction
A medication widely available over-the-counter for respiratory relief may offer a new therapeutic approach to solvent addiction, according to research conducted by scientists at the University of the Philippines National Institutes of Health.
LSN Philippines ·

Researchers at UP-NIH have identified potential benefits of N-acetylcysteine (NAC), a mucolytic agent commonly used to clear mucus in patients with coughs and respiratory conditions, in addressing the neurological effects of inhalant substance abuse.
The study, led by neuroscientist Dr. Rohani Cena-Navarro, examined how NAC may reverse damaging changes in the brain caused by solvent addiction and reduce compulsive drug-seeking behavior in affected individuals.
Solvent inhalation, a particularly prevalent form of substance abuse in several Asian communities, causes significant neurological damage and behavioral changes. The accessibility and low cost of inhalant substances make this form of addiction a persistent public health challenge in the region.
If further clinical trials confirm these preliminary findings, NAC could provide an affordable and readily available treatment option for solvent addiction. The medication's existing safety profile and widespread availability as a non-prescription drug could facilitate rapid implementation in healthcare settings throughout the Philippines and the broader region.
The research contributes to growing efforts to address the neurobiological mechanisms of inhalant addiction and develop evidence-based interventions for this challenging health issue.